Zobrazeno 1 - 10
of 675
pro vyhledávání: '"11"'
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundCholangiocarcinoma (CCA), including intrahepatic (iCCA), perihilar (pCCA), and distal (dCCA) CCA, is a highly aggressive malignancy originating from bile duct. The prognosis of CCA is very poor, and the biomarker study is unsatisfactory com
Autor:
Guangzhong Yang, Weijun Fu, Huixing Zhou, Wenming Chen, Wen Gao, Guorong Wang, Yanchen Li, Yin Wu, Yuan Jian, Zhiyao Zhang, Juan Li, Juan Du, Junru Liu, Ying Tian
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Vol 10 (2020)
Objective To investigate the prognostic value of t(11;14) for de novo multiple myeloma (MM) patients in novel agent era. Methods A total of 455 patients with fluorescence in situ hybridization (FISH), before treatments from three hospitals in China,
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
ObjectivesThe proliferation of microvessels with increased permeability is thought to be the cause of peritumoral brain edema (PTBE) in metastases. The contribution of the glymphatic system to the formation of PTBE in brain metastases remains unexplo
Autor:
Frank Emert, John Missimer, Philipp A. Eichenberger, Marc Walser, Celina Gmür, Antony J. Lomax, Damien C. Weber, Christina M. Spengler
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, 11
Emert, Frank; Missimer, John; Eichenberger, Philipp A; Walser, Marc; Gmür, Celina; Lomax, Antony J; Weber, Damien C; Spengler, Christina M (2021). Enhanced Deep-Inspiration Breath Hold Superior to High-Frequency Percussive Ventilation for Respiratory Motion Mitigation: A Physiology-Driven, MRI-Guided Assessment Toward Optimized Lung Cancer Treatment With Proton Therapy. Frontiers in oncology, 11, p. 621350. Frontiers Research Foundation 10.3389/fonc.2021.621350
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, 11
Emert, Frank; Missimer, John; Eichenberger, Philipp A; Walser, Marc; Gmür, Celina; Lomax, Antony J; Weber, Damien C; Spengler, Christina M (2021). Enhanced Deep-Inspiration Breath Hold Superior to High-Frequency Percussive Ventilation for Respiratory Motion Mitigation: A Physiology-Driven, MRI-Guided Assessment Toward Optimized Lung Cancer Treatment With Proton Therapy. Frontiers in oncology, 11, p. 621350. Frontiers Research Foundation 10.3389/fonc.2021.621350
Background: To safely treat lung tumors using particle radiation therapy (PRT), motion-mitigation strategies are of critical importance to ensure precise irradiation. Therefore, we compared applicability, effectiveness, reproducibility, and subjects'
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
BackgroundSoft pancreas is widely recognized as an important risk factor for the development of postoperative pancreatic fistula (POPF). Although fatty pancreas (FP) has not been formally defined as a cause of pancreatic fistula, existing research ha
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
ObjectiveTo evaluate the feasibility and effectivity of deep learning (DL) plus three-dimensional (3D) printing in the management of giant sporadic renal angiomyolipoma (RAML).MethodsThe medical records of patients with giant (>15 cm) RAML were retro
Autor:
Qinleng Zhang, Hui Jia, Zhendan Wang, Shaoyu Hao, Haiyan Huang, Airong Yang, Lu Han, Pingping Song
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
ObjectivesMultiple primary lung cancers (MPLCs) are an increasingly well-known clinical phenomenon, but there is a lack of high-level evidence for their optimal clinical diagnosis and therapeutic approaches. Thus, we analysed genetic variation to det
Autor:
Liangliang Yan, Yanqiao Ren, Kun Qian, Xuefeng Kan, Hongsen Zhang, Lei Chen, Bin Liang, Chuansheng Zheng
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
ObjectivesTo analyze the clinical outcomes of Transarterial chemoembolization (TACE) for unresectable or “ablation unsuitable” hepatocellular carcinoma (HCC) in the caudate lobe (CL) found at initial presentation in clinical practice.MethodsFifty
Autor:
Silvia Valtorta, Denise Toscani, Martina Chiu, Andrea Sartori, Angela Coliva, Arianna Brevi, Giuseppe Taurino, Matteo Grioni, Livia Ruffini, Federica Vacondio, Franca Zanardi, Matteo Bellone, Rosa Maria Moresco, Ovidio Bussolati, Nicola Giuliani
Publikováno v:
Frontiers in oncology 11 (2021): 760732. doi:10.3389/fonc.2021.760732
info:cnr-pdr/source/autori:Valtorta S.; Toscani D.; Chiu M.; Sartori A.; Coliva A.; Brevi A.; Taurino G.; Grioni M.; Ruffini L.; Vacondio F.; Zanardi F.; Bellone M.; Moresco R.M.; Bussolati O.; Giuliani N./titolo:[18F](2S,4R)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma/doi:10.3389%2Ffonc.2021.760732/rivista:Frontiers in oncology/anno:2021/pagina_da:760732/pagina_a:/intervallo_pagine:760732/volume:11
Frontiers in Oncology, Vol 11 (2021)
info:cnr-pdr/source/autori:Valtorta S.; Toscani D.; Chiu M.; Sartori A.; Coliva A.; Brevi A.; Taurino G.; Grioni M.; Ruffini L.; Vacondio F.; Zanardi F.; Bellone M.; Moresco R.M.; Bussolati O.; Giuliani N./titolo:[18F](2S,4R)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in Myeloma/doi:10.3389%2Ffonc.2021.760732/rivista:Frontiers in oncology/anno:2021/pagina_da:760732/pagina_a:/intervallo_pagine:760732/volume:11
Frontiers in Oncology, Vol 11 (2021)
The high glycolytic activity of multiple myeloma (MM) cells is the rationale for use of Positron Emission Tomography (PET) with18F-fluorodeoxyglucose ([18F]FDG) to detect both bone marrow (BM) and extramedullary disease. However, new tracers are acti
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in oncology 11, 754975 (2021). doi:10.3389/fonc.2021.754975
Frontiers in Oncology
Frontiers in oncology 11, 754975 (2021). doi:10.3389/fonc.2021.754975
BackgroundWhether muscle strength and physical performance should be components of sarcopenia remains controversial. This study evaluated the skeletal muscle index derived from computed tomography images at the 12th thoracic vertebra level (T12 SMI),